Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lok, C. E.
Right arrow Articles by Conly, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lok, C. E.
Right arrow Articles by Conly, J.
J Am Soc Nephrol 14:169-179, 2003
© 2003 American Society of Nephrology

Hemodialysis Infection Prevention with Polysporin Ointment

Charmaine E. Lok*,{dagger}, Kenneth E. Stanley{dagger}, Janet E. Hux*, Robert Richardson*, Sheldon W. Tobe* and John Conly*

*University of Toronto, Toronto, Canada; and {dagger}Harvard School of Public Health, Boston, Massachusetts.

Correspondence to Dr, Charmaine E. Lok, Department of Medicine, Division of Nephrology, The Toronto General Hospital, 11 EN-216, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada. Phone: 416-340-4140; Fax: 416-586-9827;

ABSTRACT. Hemodialysis patients in whom permanent vascular access cannot be achieved are dependent on a central venous catheter. In such patients, catheter-related infections are a common and serious complication. This study was a randomized clinical trial to determine if topical Polysporin Triple antibiotic ointment applied to the central venous catheter insertion site could reduce the incidence of catheter-related infections. A total of 169 patients receiving hemodialysis through a central venous catheter were randomized to receive Polysporin Triple or placebo using a double-blind study design. In the 6-mo study period, infections were observed in more patients in the placebo group than in the Polysporin Triple group (34 versus 12%; relative risk, 0.35; 95% CI, 0.18 to 0.68; P = 0.0013). The number of infections per 1000 catheter days (4.10 versus 1.02; P < 0.0001) and the number of bacteremias per 1000 catheter days (2.48 versus 0.63; P = 0.0004) were also greater in the placebo group. Within the 6-mo study period, there were 13 deaths in the placebo group as compared with 3 deaths in the Polysporin Triple group (P = 0.0041). When all available follow-up information was included, the difference in survival remained significant (19 versus 9 deaths; P = 0.0027). Within the first 6 mo, infections were observed in 7 of the 13 placebo subjects who died (54%) as compared with no infections in the three Polysporin Triple subjects who died. The prophylactic application of topical Polysporin Triple antibiotic ointment to the central venous catheter insertion site reduced the rate of infections and was associated with improved survival in hemodialysis patients. E-mail: charmaine.lok@uhn.on.ca




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
M. T. James, J. Conley, M. Tonelli, B. J. Manns, J. MacRae, B. R. Hemmelgarn, and for the Alberta Kidney Disease Network
Meta-analysis: Antibiotics for Prophylaxis against Hemodialysis Catheter-Related Infections
Ann Intern Med, April 15, 2008; 148(8): 596 - 605.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. X. Garg, T. Greene, and N. W. Levin
A well-conducted randomized trial that establishes no benefit of therapy is an important medical advance
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 52 - 55.
[Full Text] [PDF]


Home page
CJASNHome page
A. J. Bleyer
Use of Antimicrobial Catheter Lock Solutions to Prevent Catheter-Related Bacteremia
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1073 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. E. Lok, D. Appleton, C. Bhola, B. Khoo, and R. M. A. Richardson
Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton
CHAPTER 4: Vascular Access
J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S16 - S23.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. N. Foley, H. Guo, J. J. Snyder, D. T. Gilbertson, and A. J. Collins
Septicemia in the United States Dialysis Population, 1991 to 1999
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1038 - 1045.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP